Image_4_Prognostic Role of Soluble Programmed Death Ligand 1 in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.tif
The objective of this study was to explore whether soluble programmed death ligand 1 (sPD-L1) is a potential prognostic biomarker in patients with non-small cell lung cancer (NSCLC).
MethodsA comprehensive search of electronic databases was carried out. Original studies with inclusion of sPD-L1, progression-free survival, and overall survival in NSCLC were eligible. The primary endpoints were overall survival and progression-free survival. Hazard ratios (HRs) and 95% confidence intervals (CIs) were applied for data analysis.
ResultsEight studies involving 710 patients with NSCLC were included in the analysis. A pooled data analysis revealed that high levels of sPD-L1 were correlated with poorer overall survival (HR = 2.34; 95% CI = 1.82–3.00; P < 0.001) and progression-free survival (HR = 2.35; 95% CI = 1.62–3.40, P < 0.001). A subgroup analysis revealed that high levels of sPD-L1 were correlated with poor overall survival in patients treated with immunotherapy (HR = 2.40; 95% CI = 1.79–3.22; P < 0.001).
ConclusionThis pooled analysis of published data suggests that sPD-L1 may serve as a readily available biomarker for survival in NSCLC patients treated with ICI based treatment. Prospective studies with well-designed standard assessment methods should be conducted to validate the prognostic role of sPD-L1 in NSCLC.
Systematic Review Registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021283177.
History
References
- https://doi.org//10.3322/caac.21492
- https://doi.org//10.1016/j.jtho.2019.01.020
- https://doi.org//10.1038/nature22396
- https://doi.org//10.1056/NEJMoa1606774
- https://doi.org//10.1016/j.immuni.2018.03.014
- https://doi.org//10.7150/jca.21415
- https://doi.org//10.1097/JTO.0000000000000414
- https://doi.org//10.1158/1078-0432.CCR-19-1126
- https://doi.org//10.1016/j.lungcan.2021.05.013
- https://doi.org//10.3390/cancers12123625
- https://doi.org//10.1016/j.imlet.2018.09.007
- https://doi.org//10.1038/s41577-019-0264-y
- https://doi.org//10.1007/s00262-018-2271-4
- https://doi.org//10.2147/CMAR.S312690
- https://doi.org//10.18632/oncotarget.12810
- https://doi.org//10.1016/j.critrevonc.2019.08.009
- https://doi.org//10.3389/fimmu.2020.587460
- https://doi.org//10.1158/1078-0432.CCR-10-0250
- https://doi.org//10.1186/s13075-015-0859-z
- https://doi.org//10.1016/j.cllc.2018.04.014
- https://doi.org//10.3390/cancers13040667
- https://doi.org//10.1186/s12885-017-3369-3
- https://doi.org//10.1186/s40425-019-0810-y
- https://doi.org//10.1038/s41598-020-65895-0
- https://doi.org//10.3389/fonc.2020.626932
- https://doi.org//10.1007/s11523-020-00763-5
- https://doi.org//10.1097/MD.0000000000009617
- https://doi.org//10.3978/j.issn.1000-9604.2014.02.08
- https://doi.org//10.1111/1759-7714.12247
- https://doi.org//10.1136/bmj.b2535
- https://doi.org//10.1371/journal.pone.0114096
- https://doi.org//10.1136/bmj.d5928
- https://doi.org//10.2307/2533446
- https://doi.org//10.1136/bmj.315.7109.629
- https://doi.org//10.3390/cancers12061373
- https://doi.org//10.1002/ijc.31923
- https://doi.org//10.2478/jomb-2018-0036
- https://doi.org//10.21873/anticanres.13716
- https://doi.org//10.1186/s12931-018-0885-x
- https://doi.org//10.1016/j.lungcan.2016.11.023
- https://doi.org//10.1183/13993003.congress-2018.OA3302
- https://doi.org//10.1097/CJI.0000000000000315
- https://doi.org//10.1016/j.lungcan.2020.07.028
- https://doi.org//10.1111/1759-7714.13721
- https://doi.org//10.3390/cancers12020473
- https://doi.org//10.3389/fimmu.2021.665133
- https://doi.org//10.1097/MD.0000000000006102
- https://doi.org//10.1080/01635581.2019.1631859
- https://doi.org//10.3390/curroncol28050357
- https://doi.org//10.1007/s00262-021-02898-4
- https://doi.org//10.5301/jbm.5000170
- https://doi.org//10.1245/s10434-018-07112-x
- https://doi.org//10.1158/2326-6066.CIR-16-0329
- https://doi.org//10.4049/jimmunol.173.8.4919
- https://doi.org//10.1007/BF02911345
- https://doi.org//10.18632/oncotarget.24785
- https://doi.org//10.1056/NEJMoa1810865
- https://doi.org//10.1016/j.jtho.2018.11.011
- https://doi.org//10.1056/NEJMoa1507643
- https://doi.org//10.1097/CJI.0000000000000312
- https://doi.org//10.1002/bimj.200510175
CC BY 4.0